# Li Fan

> Li Fan is a Series C investor at Fosun Health Capital backing Life Science. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Fosun Health Capital](https://shizune.co/investors/profile/fosun-health-capital)
- Total investments: 1
- Last investment: Aug 2025
- Lead investor: 100%
- Last updated: Aug 2026

Li Fan is a CEO of Fujian Capital

## Contacts

5 contacts available for Li Fan: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/li-fan-a7a5?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| InxMed | InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $34M | Series C | Aug 22, 2025 |  |

1 of 1 investments shown.

## Co-investors
- Chengxiang Capital — VC Fund, 1 deal together
- Enran Chuangtou — VC Fund, 1 deal together
- [Kunlun Capital](https://shizune.co/investors/profile/kunlun-capital-153a) — VC Fund, 1 deal together
- [Prox Ventures](https://shizune.co/investors/profile/prox-ventures) — VC Fund, 1 deal together

## About Fosun Health Capital

VC Fund · Xuhui, China

Fujian Capital New Drug Innovation Fund is the first new drug innovation fund mainly based on the holding incubation model

2 contacts available at Fosun Health Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Jin Bi | Executive General Manager | — |
| Li Fan | CEO | — |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Li Fan invest in?

Li Fan invests primarily in Life Science and Biotechnology startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Li Fan?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Li Fan last invest?

The most recent investment recorded for Li Fan closed in Aug 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co